183 related articles for article (PubMed ID: 36050484)
1. Detecting early safety signals of infliximab using machine learning algorithms in the Korea adverse event reporting system.
Lee JE; Kim JH; Bae JH; Song I; Shin JY
Sci Rep; 2022 Sep; 12(1):14869. PubMed ID: 36050484
[TBL] [Abstract][Full Text] [Related]
2. Application of tree-based machine learning classification methods to detect signals of fluoroquinolones using the Korea Adverse Event Reporting System (KAERS) database.
Jang MG; Cha S; Kim S; Lee S; Lee KE; Shin KH
Expert Opin Drug Saf; 2023; 22(7):629-636. PubMed ID: 36794497
[TBL] [Abstract][Full Text] [Related]
3. Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016.
Ran J; Yang JY; Lee JH; Kim HJ; Choi JY; Shin JY
Int J Clin Pharm; 2019 Oct; 41(5):1365-1372. PubMed ID: 31313003
[TBL] [Abstract][Full Text] [Related]
4. Data-mining for detecting signals of adverse drug reactions of fluoxetine using the Korea Adverse Event Reporting System (KAERS) database.
Kim S; Park K; Kim MS; Yang BR; Choi HJ; Park BJ
Psychiatry Res; 2017 Oct; 256():237-242. PubMed ID: 28646789
[TBL] [Abstract][Full Text] [Related]
5. Bacillus Calmette-Guérin (BCG) vaccine safety surveillance in the Korea Adverse Event Reporting System using the tree-based scan statistic and conventional disproportionality-based algorithms.
Kim JH; Lee H; Shin JY
Vaccine; 2020 May; 38(21):3702-3710. PubMed ID: 32278521
[TBL] [Abstract][Full Text] [Related]
6. Signal detection of botulinum toxin type A (BoNT/A) using the Korea Adverse Event Reporting System Database, 1999 - 2016.
Lee SE; Lee SH; Shin JY
Int J Clin Pharmacol Ther; 2021 May; 59(5):386-397. PubMed ID: 33480840
[TBL] [Abstract][Full Text] [Related]
7. Signal Detection of Imipenem Compared to Other Drugs from Korea Adverse Event Reporting System Database.
Park K; Soukavong M; Kim J; Kwon KE; Jin XM; Lee J; Yang BR; Park BJ
Yonsei Med J; 2017 May; 58(3):564-569. PubMed ID: 28332362
[TBL] [Abstract][Full Text] [Related]
8. Real-world data-based adverse drug reactions detection from the Korea Adverse Event Reporting System databases with electronic health records-based detection algorithm.
Shin H; Cha J; Lee Y; Kim JY; Lee S
Health Informatics J; 2021; 27(3):14604582211033014. PubMed ID: 34289723
[TBL] [Abstract][Full Text] [Related]
9. Machine Learning for Detection of Safety Signals From Spontaneous Reporting System Data: Example of Nivolumab and Docetaxel.
Bae JH; Baek YH; Lee JE; Song I; Lee JH; Shin JY
Front Pharmacol; 2020; 11():602365. PubMed ID: 33628176
[No Abstract] [Full Text] [Related]
10. A Pilot, Predictive Surveillance Model in Pharmacovigilance Using Machine Learning Approaches.
De Abreu Ferreira R; Zhong S; Moureaud C; Le MT; Rothstein A; Li X; Wang L; Patwardhan M
Adv Ther; 2024 Jun; 41(6):2435-2445. PubMed ID: 38704799
[TBL] [Abstract][Full Text] [Related]
11. Automatic Extraction of Comprehensive Drug Safety Information from Adverse Drug Event Narratives in the Korea Adverse Event Reporting System Using Natural Language Processing Techniques.
Kim S; Kang T; Chung TK; Choi Y; Hong Y; Jung K; Lee H
Drug Saf; 2023 Aug; 46(8):781-795. PubMed ID: 37330415
[TBL] [Abstract][Full Text] [Related]
12. Signal Detection for Cardiovascular Adverse Events of DPP-4 Inhibitors Using the Korea Adverse Event Reporting System Database, 2008-2016.
Yi H; Lee JH; Shin JY
Yonsei Med J; 2019 Feb; 60(2):200-207. PubMed ID: 30666842
[TBL] [Abstract][Full Text] [Related]
13. Enhancing antidepressant safety surveillance: comparative analysis of adverse drug reaction signals in spontaneous reporting and healthcare claims databases.
Kim T; Jiang X; Noh Y; Kim M; Hong SH
Front Pharmacol; 2023; 14():1291934. PubMed ID: 38259269
[No Abstract] [Full Text] [Related]
14. Comparison of signal detection of tumour necrosis factor-α inhibitors using the Korea Adverse Events Reporting System Database, 2005-2016.
Ha D; Lee SE; Song I; Lim SJ; Shin JY
Clin Rheumatol; 2020 Feb; 39(2):347-355. PubMed ID: 31673980
[TBL] [Abstract][Full Text] [Related]
15. Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Subeesh V; Maheswari E; Singh H; Beulah TE; Swaroop AM
Curr Drug Saf; 2019; 14(1):21-26. PubMed ID: 30362421
[TBL] [Abstract][Full Text] [Related]
16. Supervised signal detection for adverse drug reactions in medication dispensing data.
Hoang T; Liu J; Roughead E; Pratt N; Li J
Comput Methods Programs Biomed; 2018 Jul; 161():25-38. PubMed ID: 29852965
[TBL] [Abstract][Full Text] [Related]
17. A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports.
Hoffman KB; Dimbil M; Tatonetti NP; Kyle RF
Drug Saf; 2016 Jun; 39(6):561-75. PubMed ID: 26946292
[TBL] [Abstract][Full Text] [Related]
18. Changing paradigms in detecting rare adverse drug reactions: from disproportionality analysis, old and new, to machine learning.
Arku D; Yousef C; Abraham I
Expert Opin Drug Saf; 2022 Oct; 21(10):1235-1238. PubMed ID: 36181369
[TBL] [Abstract][Full Text] [Related]
19. Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports.
Liu R; Zhang P
BMC Med Inform Decis Mak; 2019 Dec; 19(1):279. PubMed ID: 31849321
[TBL] [Abstract][Full Text] [Related]
20. A Comparison Study of Algorithms to Detect Drug-Adverse Event Associations: Frequentist, Bayesian, and Machine-Learning Approaches.
Pham M; Cheng F; Ramachandran K
Drug Saf; 2019 Jun; 42(6):743-750. PubMed ID: 30762164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
